Clinical Trial Update: Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica [Phase 3]

View source ↗

Summary

A Phase 3 efficacy trial comparing oral miltefosine with Glucantime for cutaneous leishmaniasis caused by Leishmania tropica has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Glucantime (meglumine antimoniate)
• Miltefosine (miltefosine)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Cutaneous Leishmaniasis | Phase 3 | Status: COMPLETED